ニュースに戻る
革新AI Understanding ブリーフィング

インシリコ・メディスンのアレックス・ザボロンコフ氏は、中国とAIが製薬業界に次のブレークスルーをもたらすことができると賭けている

インシリコ・メディスンのアレックス・ザボロンコフ氏は、中国とAIが製薬業界に次のブレークスルーをもたらすことができると信じている。

4 min readRead the original reporting
Source-provided image accompanying Insilico Medicine's Alex Zhavoronkov bets China and AI can deliver the drug industry's next breakthrough
帰属に応じたレポート記録されたソース
出版社
fortune.com
ソースリンク
fortune.comhttps://fortune.com/2026/09/18/insilico-medicine-bets-china-and-ai-can-deliver-the-drug-industry-next-breakthrough/
ソースの種類
報道機関による報道であり、自社の文書ではありません。

独自に確認できなかったもの: この主張は、指定されたアウトレットに起因します。第三者の文書と照合して検証しませんでした。 (fortune.com)

コンテキスト60秒で理解できる

ここから始めましょう

自分自身をテストしてくださいAIとは何ですか?クイズ

何が起こったのか

Insilico Medicine's Alex Zhavoronkov believes China and AI can deliver the drug industry's next breakthrough. The company is running a Phase 3 trial in China for its AI-discovered drug rentosertib, which is for idiopathic pulmonary fibrosis. Insilico used AI to identify the disease target and develop the molecule to treat it. The company has also launched LongevityBench, a test of large language models' grasp of aging biology.

インシリコ・メディスンのアレックス・ザボロンコフ氏は、中国とAIが製薬業界に次のブレークスルーをもたらすことができると信じている。

The company is running a Phase 3 trial in China for its AI-discovered drug rentosertib, which is for idiopathic pulmonary fibrosis.

Insilico used AI to identify the disease target and develop the molecule to treat it.

The company has also launched LongevityBench, a test of large language models' grasp of aging biology.

Insilico's strategy of using Chinese resources and talent to develop products for the Chinese market could be a key factor in its success.

ソースの詳細: fortune.com ↗

なぜそれが重要なのか

Insilico Medicine's success in China and its use of AI to develop drugs could be a game-changer for the pharmaceutical industry. The company's AI-discovered drug rentosertib is in Phase 3 trials, and its LongevityBench test could help improve the understanding of aging biology. Insilico's strategy of using Chinese resources and talent to develop products for the Chinese market could also be a key factor in its success.

Insilico Medicine's success in China and its use of AI to develop drugs could be a game-changer for the pharmaceutical industry.

The company's AI-discovered drug rentosertib is in Phase 3 trials, and its LongevityBench test could help improve the understanding of aging biology.

Insilico's strategy of using Chinese resources and talent to develop products for the Chinese market could also be a key factor in its success.

The company's use of AI could help improve the understanding of aging biology and lead to the development of new treatments.

Insilico's success could lead to a shift in the way drugs are developed and marketed.

Interactive Mechanism

インタラクティブなメカニズム: 実際にどのように機能するか

この開発の背後にある基盤となるテクノロジーをインタラクティブに探索します。

Thinking Budget (Test-Time Tokens):1,024 tokens
Complex Accuracy79%Math & Code Logic
Latency3.2sTime to first full output
Inference Cost$0.0092Per query estimated
Reasoning StyleStep VerificationInternal chain depth
Active Thinking Trace:
1Deconstruct user problem into formal constraints
2Propose candidate hypotheses & step-by-step calculation
3Self-correction: Backtrack and refute subtle edge cases
4Exhaustive consistency check & final output synthesis
Core takeaway: Test-time compute fundamentally changes AI economics. Instead of only scaling during pre-training, giving reasoning models more tokens at inference time allows them to systematically solve PhD-level STEM problems.
インタラクティブコンセプトチェック+10 Points
What is AI? Quiz

A route planner searches possible journeys using explicit rules. What does this illustrate about AI?

次に見るべきもの

Insilico Medicine's progress in China and its use of AI to develop drugs will be closely watched by the pharmaceutical industry. The company's success could lead to a shift in the way drugs are developed and marketed, and its use of AI could help improve the understanding of aging biology.

Insilico Medicine's progress in China and its use of AI to develop drugs will be closely watched by the pharmaceutical industry.

The company's success could lead to a shift in the way drugs are developed and marketed.

Insilico's use of AI could help improve the understanding of aging biology and lead to the development of new treatments.

The company's strategy of using Chinese resources and talent to develop products for the Chinese market could be a key factor in its success.

Insilico's success could help address the issue of longevity inequality.

関連ガイドとクイズ

AIとは何ですか?AI倫理AIエージェントAI モデルの説明AIの未来あなたが知っていることをテストする - 無料の AI クイズに挑戦してください用語集で AI 用語を検索するAI モデル リリース トラッカーをフォローする
これは役に立ちましたか?